152 related articles for article (PubMed ID: 2747625)
41. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis.
Bellanger C; Halm MP; Dauphin F; Chichery R
Neurosci Lett; 2005 Oct; 387(3):162-7. PubMed ID: 16026931
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.
Huang XP; Williams FE; Peseckis SM; Messer WS
J Pharmacol Exp Ther; 1998 Sep; 286(3):1129-39. PubMed ID: 9732369
[TBL] [Abstract][Full Text] [Related]
43. Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptors.
Schmeller T; Sporer F; Sauerwein M; Wink M
Pharmazie; 1995 Jul; 50(7):493-5. PubMed ID: 7675895
[TBL] [Abstract][Full Text] [Related]
44. Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds.
Horenstein NA; Quadri M; Stokes C; Shoaib M; Papke RL
Nicotine Tob Res; 2019 May; 21(6):805-812. PubMed ID: 29059390
[TBL] [Abstract][Full Text] [Related]
45. Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.
Reavill C; Spivak CE; Stolerman IP; Waters JA
Neuropharmacology; 1987 Jul; 26(7A):789-92. PubMed ID: 3627386
[TBL] [Abstract][Full Text] [Related]
46. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors.
Bakry NM; el-Rashidy AH; Eldefrawi AT; Eldefrawi ME
J Biochem Toxicol; 1988; 3():235-59. PubMed ID: 3236334
[TBL] [Abstract][Full Text] [Related]
47. Anatoxin-a interactions with cholinergic synaptic molecules.
Aronstam RS; Witkop B
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4639-43. PubMed ID: 6270690
[TBL] [Abstract][Full Text] [Related]
48. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
Wonnacott S; Jackman S; Swanson KL; Rapoport H; Albuquerque EX
J Pharmacol Exp Ther; 1991 Oct; 259(1):387-91. PubMed ID: 1920126
[TBL] [Abstract][Full Text] [Related]
49. Nitrile oxides in medicinal chemistry. 3. Synthesis and bioenantioselectivity of (+)- and (-)-2-methyl-5-[(dimethylamino)-methyl]-3-oxo-isoxazolidine methiodide.
De Amici M; De Micheli C; Grana E; Lucchelli A; Zonta F
Farmaco; 1990 Jul; 45(7-8):859-66. PubMed ID: 2282119
[TBL] [Abstract][Full Text] [Related]
50. Interactions of noncompetitive inhibitors with nicotinic receptors in the rat brain.
Takayama H; Majewska MD; London ED
J Pharmacol Exp Ther; 1989 Dec; 251(3):1083-9. PubMed ID: 2600805
[TBL] [Abstract][Full Text] [Related]
51. Neurotransmitter receptors as targets for pesticides.
Eldefrawi ME; Eldefrawi AT
J Environ Sci Health B; 1983; 18(1):65-88. PubMed ID: 6339601
[TBL] [Abstract][Full Text] [Related]
52. Autoradiographic localization of binding sites for muscarinic and nicotinic agonists and antagonists on cultured astrocytes.
Hösli E; Hösli L
Exp Brain Res; 1988; 71(2):450-4. PubMed ID: 3169176
[TBL] [Abstract][Full Text] [Related]
53. The Neurotoxic Effect of 13,19-Didesmethyl and 13-Desmethyl Spirolide C Phycotoxins Is Mainly Mediated by Nicotinic Rather Than Muscarinic Acetylcholine Receptors.
Aráoz R; Ouanounou G; Iorga BI; Goudet A; Alili D; Amar M; Benoit E; Molgó J; Servent D
Toxicol Sci; 2015 Sep; 147(1):156-67. PubMed ID: 26063663
[TBL] [Abstract][Full Text] [Related]
54. [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor.
Eldefrawi ME; Eldefrawi AT; Aronstam RS; Maleque MA; Warnick JE; Albuquerque EX
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7458-62. PubMed ID: 6261260
[TBL] [Abstract][Full Text] [Related]
55. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.
Whiteaker P; Garcha HS; Wonnacott S; Stolerman IP
Br J Pharmacol; 1995 Oct; 116(3):2097-105. PubMed ID: 8640351
[TBL] [Abstract][Full Text] [Related]
56. (+-)-Octahydro-2-methyl-trans-5 (1H)-isoquinolone methiodide: a probe that reveals a partial map of the nicotinic receptor's recognition site.
Spivak CE; Waters JA; Yadav JS; Shang WC; Hermsmeier M; Liang RF; Gund TM
J Mol Graph; 1991 Jun; 9(2):105-10, 100-1. PubMed ID: 1768639
[TBL] [Abstract][Full Text] [Related]
57. Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.
Reavill C; Waters JA; Stolerman IP; Garcha HS
Psychopharmacology (Berl); 1990; 102(4):521-8. PubMed ID: 2096409
[TBL] [Abstract][Full Text] [Related]
58. Binding of soman antidotes to acetylcholine receptors.
Broomfield C; Dembure IJ; Cuculis J
Biochem Pharmacol; 1987 Apr; 36(7):1017-22. PubMed ID: 3566797
[TBL] [Abstract][Full Text] [Related]
59. Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor.
Kawai H; Raftery MA
J Biochem; 2010 May; 147(5):743-9. PubMed ID: 20123701
[TBL] [Abstract][Full Text] [Related]
60. Anticholinergic activity in mice and receptor-binding properties in rats of a series of synthetic tropane derivatives.
Gao ZG; Cui WY; Liu BY; Liu CG; Wang L
J Pharm Pharmacol; 1997 Mar; 49(3):315-8. PubMed ID: 9231353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
